Gedeon Richter saw the highest growth of 5.99% in patent filings and 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Gedeon Richter‘s patent filings and grants. Buy the databook here.
Gedeon Richter has been focused on protecting inventions in Australia(AU) with three publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 33% of filings. The Australia(AU), Israel(IL), Colombia(CO), and Denmark(DK) patent Office are among the top ten patent offices where Gedeon Richter is filings its patents. Among the top granted patent authorities, Gedeon Richter has 29% of its grants in Hungary(HU).
Roche and Johnson & Johnson could be the strongest competitors for Gedeon Richter
Patents related to climate change and cell & gene therapy lead Gedeon Richter's portfolio
Gedeon Richter has the highest number of patents in climate change followed by, cell & gene therapy. For climate change no patents were filed and 50% of patents were granted in Q2 2024.
Autism spectrum disorder (asd) related patents lead Gedeon Richter portfolio followed by asperger syndrome, and rett syndrome
Gedeon Richter has highest number of patents in autism spectrum disorder (asd) followed by asperger syndrome, rett syndrome, attention deficit hyperactivity disorder (adhd), and major depressive disorder. For autism spectrum disorder (asd), nearly 14% of patents were filed and 18% of patents were granted in Q2 2024.
For comprehensive analysis of Gedeon Richter's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.